Carbidopa and levodopa
- Product NDC
- 51862-079
- 11-digit product format
- 518620079
- Labeler code
- 51862
- Product ID
- 51862-079_2cd84ede-15ed-4200-a4b5-e070eddb27e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbidopa and levodopa
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mayne Pharma Inc.
- Application
- ANDA074260
- Marketing category
- ANDA
- Marketing start
- 2016-07-18
- Marketing end
- 2022-07-31
- Substance
- CARBIDOPA; LEVODOPA
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Aromatic Amino Acid [EPC],Amino Acids, Aromatic [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51862-079-01 | 51862007901 | 100 TABLET in 1 BOTTLE (51862-079-01) | 100 tablet | 2016-07-18 | 2022-07-31 | No | No | Current |
| 51862-079-05 | 51862007905 | 500 TABLET in 1 BOTTLE (51862-079-05) | 500 tablet | 2016-07-18 | 2022-03-31 | No | No | Current |
| 51862-079-10 | 51862007910 | 1000 TABLET in 1 BOTTLE (51862-079-10) | 1000 tablet | 2016-07-18 | 2022-05-31 | No | No | Current |